T2 Biosystems CS (TTOO)

$0.08 -0.06 (-41.49%)
Market Cap 4.09M
Revenue (ttm) 7.19M
Net Income (ttm) -50.08M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -696.52%
Debt to Equity Ratio 0.00
Volume 4,010,500
Avg Vol 1,494,488
Day's Range N/A - N/A
Shares Out 21.04M
Stochastic %K 5%
Beta 0.35
Analysts Hold
Price Target $5.00

Company Profile

T2 Biosystems, Inc. engages in the development and commercialization of medical diagnostic products for critical unmet needs in the healthcare. Its products include T2Dx instrument, T2Candida panel, and T2Bacteria panel. The company was incorporated in 2006 and is based in Lexington, Massachusetts.

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 781 761 4646
Address:
101 Hartwell Avenue, Lexington, United States
thedonutman
thedonutman Dec. 30 at 3:19 AM
$TTOO there is no 8K.
1 · Reply
__Chucky
__Chucky Dec. 30 at 2:09 AM
$TTOO I just asking a simple question as to "WHY" the Ai was saying 0.07........... Stop talking like you're some kind of genius. It took you 2 fken days to figure out, Merwin on ST was a fake account.
1 · Reply
tcamp923
tcamp923 Dec. 30 at 1:37 AM
$TTOO your A.I. skipped 2024 bruh but then again, this is why we don’t use A.I. for due diligence…
1 · Reply
GatorYoYo
GatorYoYo Dec. 30 at 12:29 AM
$TTOO strong year.... 😅😂😂
0 · Reply
Zefram
Zefram Dec. 30 at 12:10 AM
$TTOO LOL you dumbasses still think you're getting $100 million for ip that no one wanted when there was support and people working on it? LOOOOOOOOOOOL damn, some of yall are dumb.
0 · Reply
HighStreetHero
HighStreetHero Dec. 29 at 11:55 PM
$TTOO by closing out a private sale of their share by end of year, CRG locks in capital gains rates for 2025 and lets the buyer manage the remaining pieces. I'm thinking we get an update sooner than later.
1 · Reply
tcamp923
tcamp923 Dec. 29 at 11:54 PM
$TTOO idk why we’re making this so difficult CRG is still owed ~$10 million on top of their equity stake So common shareholders get whatever value is left over after $10MM goes to CRG 1st So if T2 is sold for $100MM, common shareholders would realize $90MM in valuation divided by total outstanding shares (~20MM)… which in this example would be about $5/share CRG’s equity cost basis was last reported to be around $3-5/share after their back-to-back debt for equity swaps
1 · Reply
tcamp923
tcamp923 Dec. 29 at 11:25 PM
$TTOO CRG exited T2 for 1 of 2 reasons 1) they sold their position to a buyer, and we will be notified very soon (within 2 weeks imo) 2) they sold their position to a buyer, and we will be notified very soon You cannot simply “exit” an investment without selling/closing your position… The only remaining questions are 1) how much did they sell for and 2) to whom? my opinion, anyway
1 · Reply
Zefram
Zefram Dec. 29 at 11:15 PM
$TTOO look! someone who actually asked ai a good question. LOL cRg OwNs 69%..... droolers. gg no re. there goes that theory about crg holding on for dear life to recoup their money... like ive said. funds and lenders get it wrong also. ttoo doesnt have to file for bankruptcy for this to be over. (ive also said this).
0 · Reply
Stockwatch2025
Stockwatch2025 Dec. 29 at 7:47 PM
$TTOO https://crglp.com/portfolio/exited
3 · Reply
Latest News on TTOO
No data available.
thedonutman
thedonutman Dec. 30 at 3:19 AM
$TTOO there is no 8K.
1 · Reply
__Chucky
__Chucky Dec. 30 at 2:09 AM
$TTOO I just asking a simple question as to "WHY" the Ai was saying 0.07........... Stop talking like you're some kind of genius. It took you 2 fken days to figure out, Merwin on ST was a fake account.
1 · Reply
tcamp923
tcamp923 Dec. 30 at 1:37 AM
$TTOO your A.I. skipped 2024 bruh but then again, this is why we don’t use A.I. for due diligence…
1 · Reply
GatorYoYo
GatorYoYo Dec. 30 at 12:29 AM
$TTOO strong year.... 😅😂😂
0 · Reply
Zefram
Zefram Dec. 30 at 12:10 AM
$TTOO LOL you dumbasses still think you're getting $100 million for ip that no one wanted when there was support and people working on it? LOOOOOOOOOOOL damn, some of yall are dumb.
0 · Reply
HighStreetHero
HighStreetHero Dec. 29 at 11:55 PM
$TTOO by closing out a private sale of their share by end of year, CRG locks in capital gains rates for 2025 and lets the buyer manage the remaining pieces. I'm thinking we get an update sooner than later.
1 · Reply
tcamp923
tcamp923 Dec. 29 at 11:54 PM
$TTOO idk why we’re making this so difficult CRG is still owed ~$10 million on top of their equity stake So common shareholders get whatever value is left over after $10MM goes to CRG 1st So if T2 is sold for $100MM, common shareholders would realize $90MM in valuation divided by total outstanding shares (~20MM)… which in this example would be about $5/share CRG’s equity cost basis was last reported to be around $3-5/share after their back-to-back debt for equity swaps
1 · Reply
tcamp923
tcamp923 Dec. 29 at 11:25 PM
$TTOO CRG exited T2 for 1 of 2 reasons 1) they sold their position to a buyer, and we will be notified very soon (within 2 weeks imo) 2) they sold their position to a buyer, and we will be notified very soon You cannot simply “exit” an investment without selling/closing your position… The only remaining questions are 1) how much did they sell for and 2) to whom? my opinion, anyway
1 · Reply
Zefram
Zefram Dec. 29 at 11:15 PM
$TTOO look! someone who actually asked ai a good question. LOL cRg OwNs 69%..... droolers. gg no re. there goes that theory about crg holding on for dear life to recoup their money... like ive said. funds and lenders get it wrong also. ttoo doesnt have to file for bankruptcy for this to be over. (ive also said this).
0 · Reply
Stockwatch2025
Stockwatch2025 Dec. 29 at 7:47 PM
$TTOO https://crglp.com/portfolio/exited
3 · Reply
HighStreetHero
HighStreetHero Dec. 29 at 7:25 PM
$TTOO the "Exited" status is likely a major update. This tells me we should expect something in the next 4 business days. IMO, bankruptcy is gone.
2 · Reply
BennaG
BennaG Dec. 29 at 6:42 PM
$TTOO now its showing on CRG's website as "exited" and not as "current" investment.. Hmm.
5 · Reply
bjay11
bjay11 Dec. 29 at 3:37 PM
$TTOO nice volume pop 💥
1 · Reply
Zefram
Zefram Dec. 29 at 3:35 AM
$TTOO isnt it funny how when all these little articles and press releases about commercial expansion showed up... i said they were nothing burgers.. and i was completely right? should have just listened to me when i gave you the read on EVERY single press release, filing, and research paper... i was always 100% right... while the biggest bulls and bagholders were absolutely wrong... on. every. single. thing. easy to see really. you guys still dont understand how easy it is to pay for positive media do ya?
0 · Reply
vincent_2025
vincent_2025 Dec. 28 at 4:21 AM
$TTOO Feb 2024 ...older article but has some interesting info, imo. https://finance.yahoo.com/news/t2-biosystems-announces-commercial-expansion-210200558.html
0 · Reply
vincent_2025
vincent_2025 Dec. 28 at 4:02 AM
$TTOO Ai Gemini info. (recommend DD ) While Cardinal Health dominates the U.S. landscape, Biomedica remains T2 Biosystems’ critical strategic partner for Central and Eastern Europe (CEE) and the DACH region (Germany, Austria, Switzerland) in late 2025. Strategic Importance in 2025 For T2 Biosystems, Biomedica acts as the "international mirror" to Cardinal Health Revenue Contribution: In the first half of 2025, international sales (largely driven by Biomedica in Europe and partners in Asia) provided the necessary cash flow to support T2’s U.S. restructuring efforts. Also found interesting info on Gemini, regarding Cardinal Health's active role w/ T2MR in 2025. (Gemini can make mistakes, so double-check it )
0 · Reply
Zefram
Zefram Dec. 27 at 8:55 PM
$TTOO LOL the ebay listings for t2 biosystems junk on ebay looks like a junkyard sale from the Fallout universe.
0 · Reply
Zefram
Zefram Dec. 27 at 8:54 PM
$TTOO watch how easy it is to manipulate the narrative on this board.
0 · Reply
vincent_2025
vincent_2025 Dec. 27 at 11:03 AM
$TTOO
2 · Reply
vincent_2025
vincent_2025 Dec. 27 at 10:07 AM
$TTOO AI info (DD required) The "Lysis update" refers to a critical improvement in how the T2Dx instrument processes whole blood. This new process is the backbone of the company’s recent patent extensions and its ability to detect pathogens that other systems miss. Traditionally, T2 Biosystems used a mechanical "bead beating" process to break open (lyse) cells. The updated process is a more sophisticated, automated multi-step lysis that allows for a much cleaner separation of pathogen DNA from human blood. 1. What is the New Lysis Process? The updated method, which was a key part of the patent defense against bioMérieux in late 2024, involves a two-stage approach inside the T2Dx cartridge Selective RBC Lysis: The system first uses a proprietary "Lysis Reagent" to dissolve Red Blood Cells while leaving the target bacteria or fungi intact. see reply for continuation...
4 · Reply
charlieshim2015
charlieshim2015 Dec. 27 at 9:39 AM
$TTOO Any update on buyout or M&A news? If there is any, please share! Can't wait to hear this exciting news in 2026!
2 · Reply
vincent_2025
vincent_2025 Dec. 27 at 2:16 AM
$TTOO T2 Patent extension info ( your DD required to verify)
1 · Reply